5th NASH Roundtable™ Virtual Forum
The 5th NASH Roundtable™ Virtual Forum was held on June 16, 2022, with presentations focused on the use of digital pathology for histology in NASH drug development.
Forum Co-Chairs and Moderators
Cindy Serdjebi, PharmD, PhD Head of Research and Development, Biocellvia
Mathieu Petitjean, PhD Chief Executive Officer, PHARMANEST
Janani Iyer, PhD Scientific Program Manager, PathA
Anil Parwani, MD, PhD Vice Chair, Anatomical Pathology, and Director, Pathology Informatics and Digital Pathology, The Ohio State University, Wexner Medical Center
About the NASH Roundtable™
The NASH Roundtable™ was established in 2018 as a platform to stimulate collaboration and build consensus towards validated biomarkers and endpoints and to support the development of effective and safe treatments. Today the Roundtable consists of distinguished physicians, researchers, and clinical development experts from three continents brought together by their common commitment to steward advances in science, clinical research, and therapeutics for fibrotic diseases.